Download PDF
Thromb Haemost 1965; 14(03/04): 387-400
DOI: 10.1055/s-0038-1654877
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Studies on the Adsorption and Activation of the Hageman Factor (Factor XII) by Collagen and Elastin[*]

St Niewiarowski
1   Department of Physiological Chemistry, Medical School, Bialystok, Poland
,
E Bańkowski
1   Department of Physiological Chemistry, Medical School, Bialystok, Poland
,
Irena Rogowicka
1   Department of Physiological Chemistry, Medical School, Bialystok, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

It has been found that Hageman factor is adsorbed from normal human plasma by collagen and elastin. The adsorption is dependent upon the concentration of both substances and upon the adsorption time. The adsorption by collagen is almost selective. By the procedure of the repeated adsorption it is possible to obtain plasma containing 3-5% of Hageman factor normal value and normal amount of PTA (factor XI). At pH 9.5-10.0 the Hageman factor can be eluted in part from collagen shaken previously with human or pig plasma, its recovery in the eluates from elastin is poor.

Experimental evidence is presented that the Hageman factor is activated following adsorption on collagen. The eluates from collagen have been compared with those prepared in a similar manner from kaolin and celite. All eluates possess clot promoting, TAMe arginine esterase and fibrinolytic activities. They shorten considerably the clotting time of the whole blood in siliconized tubes.

It has been suggested that collagen may act as an intrinsic trigger of the blood coagulation in vivo by adsorbing and activating the Hageman factor.

* Aided in part by the Polish Academy of Sciences, Department VI.


 

  • References

  • 1 Astrup T, Müllertz S. The fibrin plate method for estimation fibrinolytic activity. Arch. Biochem. 40: 346 1952;
    CrossrefPubMedGoogle Scholar
  • 2 Bankowski E, Fiedoruk T. In preparation..
    PubMedGoogle Scholar
  • 3 Bell W. N, Alton H. J. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature 174: 880 1954;
    CrossrefPubMedGoogle Scholar
  • 4 Biggs R, Sharp A, Margolis J, Hardisty R. M, Stewart J, Davidson W. M. Defects in the early stages of blood coagulation, a report of four cases. Brit. J. Haemat. 04: 177 1958;
    CrossrefPubMedGoogle Scholar
  • 5 Bounameaux V, Hugues J. L’adhesion des plaquettes aux levres de la plaie vasculaire et entre elles. Proc. of the Intern. Union of Physiol. Sciences, Leyden. 01: 224 1959;
    PubMedGoogle Scholar
  • 6 Davie E. W, Ratnoff O. D. Waterfall sequence for intrinsic blood clotting. Science 145: 1310 1964;
    CrossrefPubMedGoogle Scholar
  • 7 Einbinder J, Schubert H. Binding of mucopolysaccharides and dyes by collagen. J. biol. Chem. 188: 335 1950;
    PubMedGoogle Scholar
  • 8 Hardisty R. M, Margolis J. The role of Hageman Factor in the initiation of blood coagulation. Brit. J. Hemat. 05: 203 1959;
    CrossrefPubMedGoogle Scholar
  • 9 Harrington W. F, von Hippel P. H. The structure of collagen and gelatin. Advanc. Protein Chem. 16: 1 1961;
    PubMedGoogle Scholar
  • 10 Hovig T. Aggregation of rabbit platelets produced in vitro by saline “extract” of tendons. Thrombos. Diathes. haemorrh. (Stuttg) 09: 248 1963;
    PubMedGoogle Scholar
  • 11 Iatridis S. G, Ferguson J. H. Effect of surface and Hageman Factor on the endogenous or spontaneous activation of the fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg) 06: 411 1961;
    PubMedGoogle Scholar
  • 12 Iatridis S. G, Ferguson J. H. Active Hageman Factor a plasma lysokinase of the human fibrinolytic system. J. clin. Invest 41: 1277 1962;
    CrossrefPubMedGoogle Scholar
  • 13 Johnston C. L, Ferguson J. H, O’Hanlon F. A. Surface activation of plasma clotting. A function of Hageman Factor. Proc. soc. exp. Biol. (N. Y) 99: 197 1958;
    PubMedGoogle Scholar
  • 14 Koller F, Loeliger A, Duckert F. Experiments on a new clotting factor. Acta haemat. (Basel) 06: 1 1951;
    CrossrefPubMedGoogle Scholar
  • 15 Lowry O. H, Rosenbrough N. I, Farr A. L, Randall R. J. Protein measurement with the Folin phenol reagent. J. biol. Chem. 193: 265 1951;
    PubMedGoogle Scholar
  • 16 Macfarlane R. G. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature 202: 498 1964;
    CrossrefPubMedGoogle Scholar
  • 17 Margolis J. Activation of plasma by contact with glass, evidence for a common reaction which releases plasma kinin and initiates coagulation. J. Physiol. 144: 1 1958;
    PubMedGoogle Scholar
  • 18 Margolis J. The interrelationship of coagulation of plasma and release of peptides. Ann. N.Y. Acad. Sci. 104: 133 1963;
    PubMedGoogle Scholar
  • 19 Markwardt F, Walsman P. Die Reaktion zwischen Hirudin und Thrombin. Z. physiol. Chem. 312: 85 1958;
    CrossrefPubMedGoogle Scholar
  • 20 Miale J. B. Laboratory Medicine Hematology. Henry Kimpton. 1958
    PubMedGoogle Scholar
  • 21 Niewiarowski S, Prou-Wartelle O. Role du facteur contact (Facteur Hageman) dans la fibrinolyse. Thrombos. Diathes. haemorrh. (Stuttg) 03: 593 1959;
    PubMedGoogle Scholar
  • 22 Niewiarowski S, Stachurska J, Wçgrzynowicz Z. Arginine esterase activity of the Hageman Factor. Thrombos. Diathes. haemorrh. (Stuttg) 07: 514 1962;
    PubMedGoogle Scholar
  • 23 Niewiarowski S, Glinska-Gliniak T. Studies on contact activation in plasma of various vertebrates and patients with congenital PTA and Hageman Factor déficiences. Bull. Acad. pol. Sci. Cl. 2. 22: 191 1964;
    PubMedGoogle Scholar
  • 24 Niewiarowski S, Bankowski E, Fiedoruk T. Adsorption of Hageman Factor (Factor XII) on collagen. Experientia 20: 367 1964;
    CrossrefPubMedGoogle Scholar
  • 25 Nossel H. L. The contact phase of blood coagulation: Blackwell Scientific. Publication; Oxford: 1964
    Google Scholar
  • 26 Partridge S. M, Davis H. F, Adair G. S. Soluble proteins derived from partial hydrolysis of elastin. Biochem. J. 61: 11 1955;
    CrossrefPubMedGoogle Scholar
  • 27 Quick A. J. Lea and Febiger. Philadelphia. 1954
    PubMedGoogle Scholar
  • 28 Ratnoff O. D, Rosenblum J. M. Role of Hageman Factor in the initiation of clotting by glass. Amer. J. Med. 25: 160 1958;
    CrossrefPubMedGoogle Scholar
  • 29 Ratnoff O. D, Crum J. D. Activation of Hageman Factor by solutions of ellagic acid. J. Lab. clin. Med. 63: 359 1964;
    PubMedGoogle Scholar
  • 30 Soulier J. P, Larrieu M. J. Etude analytique des temps de Quick allonges. Dosage de prothrombine, de proconvertine et de proaccelerine. Sang. 23: 549 1952;
    PubMedGoogle Scholar
  • 31 Soulier J. P, Larrieu M. J. Nouvelle methode de diagnostic de l’hémophilie dosage des facteurs antihémophiliques A et B. Sang. 24: 205 1953;
    PubMedGoogle Scholar
  • 32 Soulier J. P, Prou-Wartelle O. New data on Hageman Factor and plasma thromboplastin antecedent: the role of “contact” in the initial phase of blood coagulation. Brit. J. Haemat. 06: 88 1960;
    CrossrefPubMedGoogle Scholar
  • 33 Vroman L. Surface contact and thromboplastin formation. Thesis, Utrecht. 1958
    PubMedGoogle Scholar
  • 34 Waaler B. A. Contact activation in the intrinsic blood clotting system. University Press. Oslo: 1959
    Google Scholar
  • 35 Wolf P. A modification for routine laboratory use of Stefanini’s method of estimating Factor V activity in human oxalated plasma. J. clin. Path. 06: 34 1953;
    CrossrefPubMedGoogle Scholar
  • 36 Zucker M. B. General observations on hemostasis. Proc. of the Intern. Union of Physiol., Sciences, Leyden. 01: 219 1962;
    PubMedGoogle Scholar